RetractedArticleNature communications2022

Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.

Alok Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.